BridgeMD
New treatment option for Hematologic Diseases
Official title The Interplay Between Inborn Error of Immunity and Blood Disorders: Unravelling Immune Defects Behind Common Haematological Diseases
ClinicalTrials.gov ID: NCT06857604
What this study is testing
- What it's testing
- The universe of Inborn errors of Immunity (IEI) is rapidly expanding: their clinical spectrum is not only characterised by infections but often includes haematological complications. Moreover, an increasing number of "IEI phenocopies" due to somatic mutations in specific cell types are progressively being unveiled and complicate the genetic plot of IEI, which are therefore not only caused by germline mutations.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages up to 25
You may be able to join if
- Patients age \< 25 years
- Patients with diagnosed autoimmune cytopenias (AIC), polyclonal lymphoproliferation (PL), lymphoma (ML), bone marrow failure, and myelodysplastic...
- Signed Informed Consent
You likely can't join if
- Patients with Lymphoma secondary to HIV or transplant
- Patient with self-resolving or post-infective AICs
The study team makes the final eligibility decision.
Where it's taking place
- Montreal, Canada, Canada
- Paris, France, France
- Florence, Fi, Italy
- Rome, Italy, Italy
- Barcelona, Spain
- Stockholm, Sweden, Sweden
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, up to 25 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Montreal, Canada, Canada; Paris, France, France; Florence, Fi, Italy; Rome, Italy, Italy; Barcelona, Spain; Stockholm, Sweden, Sweden. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.